Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5a622880e2b6f4f3ca9138eec9143e2 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2003-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a00736ac6127f5bc72efb361341a762 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e00bb9890351e5e5155250d606b6afb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e58908956f8fd3632d088b4d0194cfd |
publicationDate |
2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2005132796-A |
titleOfInvention |
Pharmaceutical compositions and methods for the treatment of granulation tissue-forming diseases |
abstract |
PROBLEM TO BE SOLVED: To prevent and / or treat chronic granulomatous inflammation, inflammatory symptoms at the time of organ transplant rejection, and pharmaceutical composition therefor by controlling tissue remodeling represented by granulation tissue formation The purpose is to provide. A method for preventing and / or treating a granulation tissue-forming disease, including specifically inhibiting the function of macrophage galactose-type C-type lectin (MGL) on macrophages, and prevention and / or treatment of granulation tissue-forming disease A therapeutic pharmaceutical composition is provided. [Selection] Figure 4 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018043012-A1 |
priorityDate |
2003-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |